-
Mar 9, 2022
Slenyto is now available in Spain!
-
Mar 2, 2022
Neurim Pharmaceuticals is attending World Sleep Congress 2022, March 11-16, Rome, Italy (Read more)
-
Feb 8, 2022
Neurim conducted a survey via Brandman Research, assessing the characteristics of insomnia in children with ASD and the distress it causes to the children and their families (Read more)
-
Jan 17, 2022
Neurim collaborated with Azrieli National Center for Autism and Neurodevelopment Research to assess the burden of Insomnia in children with autism (Read more)
-
Oct 4, 2021
Slenyto is now available in Portugal!
-
Apr 22, 2020
Slenyto (PedPRM) is now available in France!
-
Feb 11, 2020
Slenyto (PedPRM) is now available in Denmark!
-
Jan 27, 2020
Slenyto (PedPRM) is now also available in Iceland!
-
Jan 14, 2020
Slenyto (PedPRM) is now available in Switzerland!
-
Sep 18, 2019
Slenyto (PedPRM) is now available in Norway!
-
Jun 27, 2019
Neurim Pharmaceuticals attends the ESCAP Congress in Vienna, Austria, 30 June – 2 July 2019
-
May 23, 2019
Slenyto (PedPRM) is now also available in Italy!
-
Apr 8, 2019
Neurim Pharmaceuticals attends the EPA Congress in Warsaw, Poland, April 7-9, 2019
-
Apr 3, 2019
Slenyto (PedPRM) is now also available in UK!
-
Apr 1, 2019
Slenyto is now available in Finland
-
Jan 27, 2019
Slenyto is now available in Germany
-
Recent news
- Slenyto is now available in Spain!
- Neurim Pharmaceuticals is attending World Sleep Congress 2022, March 11-16, Rome, Italy
- Neurim conducted a survey via Brandman Research, assessing the characteristics of insomnia in children with ASD and the distress it causes to the children and their families